Capital Fund Management (CFM)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-227,078
| Closed | -$7.96M | – | 1031 |
|
|
2019
Q1 | $7.96M | Sell |
227,078
-75,577
| -25% | -$2.65M | 0.07% | 158 |
|
|
2018
Q4 | $10.1M | Buy |
302,655
+68,478
| +29% | +$2.27M | 0.09% | 91 |
|
|
2018
Q3 | $11.8M | Sell |
234,177
-21,285
| -8% | -$1.07M | 0.06% | 153 |
|
|
2018
Q2 | $15.3M | Buy |
255,462
+131,060
| +105% | +$7.84M | 0.08% | 111 |
|
|
2018
Q1 | $5.7M | Buy |
124,402
+33,536
| +37% | +$1.54M | 0.03% | 321 |
|
|
2017
Q4 | $3.62M | Buy |
+90,866
| New | +$3.62M | 0.02% | 368 |
|
|
2016
Q1 | – | Sell |
-35,800
| Closed | -$481K | – | 1087 |
|
|
2015
Q4 | $481K | Buy |
+35,800
| New | +$481K | ﹤0.01% | 566 |
|
|
2015
Q1 | – | Sell |
-31,100
| Closed | -$258K | – | 928 |
|
|
2014
Q4 | $258K | Buy |
+31,100
| New | +$258K | ﹤0.01% | 614 |
|